Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Giant cell angiofibroma or localized periorbital lymphedema?

Identifieur interne : 003B41 ( Main/Exploration ); précédent : 003B40; suivant : 003B42

Giant cell angiofibroma or localized periorbital lymphedema?

Auteurs : Michael C. Lynch [États-Unis] ; Catherine G. Chung [États-Unis] ; Charles S. Specht [États-Unis] ; Michael Wilkinson [États-Unis] ; Loren E. Clarke [États-Unis]

Source :

RBID : ISTEX:D4EA5C723196CCF27BF3340577107CE2599821FF

Descripteurs français

English descriptors

Abstract

Giant cell angiofibroma represents a rare soft tissue neoplasm with a predilection for the orbit. We recently encountered a mass removed from the lower eyelid of a 56‐year‐old female that histopathologically resembled giant cell angiofibroma. The process consisted of haphazardly arranged CD34‐positive spindled and multinucleated cells within an edematous, densely vascular stroma. However, the patient had recently undergone laryngectomy and radiotherapy for a laryngeal squamous cell carcinoma. A similar mass had arisen on the contralateral eyelid, and both had developed several months post‐therapy. Lymphedema of the orbit can present as tumor‐like nodules and in some cases may share histopathologic features purported to be characteristic of giant cell angiofibroma. A relationship between giant cell angiofibroma and lymphedema has not been established, but our case suggests there may be one. The potential overlap of these two conditions should be recognized, as should other entities that may enter the differential diagnosis.

Url:
DOI: 10.1111/cup.12225


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Giant cell angiofibroma or localized periorbital lymphedema?</title>
<author>
<name sortKey="Lynch, Michael C" sort="Lynch, Michael C" uniqKey="Lynch M" first="Michael C." last="Lynch">Michael C. Lynch</name>
</author>
<author>
<name sortKey="Chung, Catherine G" sort="Chung, Catherine G" uniqKey="Chung C" first="Catherine G." last="Chung">Catherine G. Chung</name>
</author>
<author>
<name sortKey="Specht, Charles S" sort="Specht, Charles S" uniqKey="Specht C" first="Charles S." last="Specht">Charles S. Specht</name>
</author>
<author>
<name sortKey="Wilkinson, Michael" sort="Wilkinson, Michael" uniqKey="Wilkinson M" first="Michael" last="Wilkinson">Michael Wilkinson</name>
</author>
<author>
<name sortKey="Clarke, Loren E" sort="Clarke, Loren E" uniqKey="Clarke L" first="Loren E." last="Clarke">Loren E. Clarke</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D4EA5C723196CCF27BF3340577107CE2599821FF</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1111/cup.12225</idno>
<idno type="url">https://api.istex.fr/document/D4EA5C723196CCF27BF3340577107CE2599821FF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006386</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006386</idno>
<idno type="wicri:Area/Istex/Curation">006386</idno>
<idno type="wicri:Area/Istex/Checkpoint">000169</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000169</idno>
<idno type="wicri:doubleKey">0303-6987:2013:Lynch M:giant:cell:angiofibroma</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:24117715</idno>
<idno type="wicri:Area/PubMed/Corpus">001892</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001892</idno>
<idno type="wicri:Area/PubMed/Curation">001892</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001892</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001892</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001892</idno>
<idno type="wicri:Area/Ncbi/Merge">005E20</idno>
<idno type="wicri:Area/Ncbi/Curation">005E20</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005E20</idno>
<idno type="wicri:Area/Main/Merge">003B50</idno>
<idno type="wicri:Area/Main/Curation">003B41</idno>
<idno type="wicri:Area/Main/Exploration">003B41</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Giant cell angiofibroma or localized periorbital lymphedema?</title>
<author>
<name sortKey="Lynch, Michael C" sort="Lynch, Michael C" uniqKey="Lynch M" first="Michael C." last="Lynch">Michael C. Lynch</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, The Penn State Hershey Medical Center, PA, Hershey</wicri:regionArea>
<wicri:noRegion>Hershey</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Chung, Catherine G" sort="Chung, Catherine G" uniqKey="Chung C" first="Catherine G." last="Chung">Catherine G. Chung</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, The Penn State Hershey Medical Center, PA, Hershey</wicri:regionArea>
<wicri:noRegion>Hershey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Specht, Charles S" sort="Specht, Charles S" uniqKey="Specht C" first="Charles S." last="Specht">Charles S. Specht</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, The Penn State Hershey Medical Center, Hershey, PA</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Ophthalmology, The Penn State Hershey Medical Center, PA, Hershey</wicri:regionArea>
<wicri:noRegion>Hershey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wilkinson, Michael" sort="Wilkinson, Michael" uniqKey="Wilkinson M" first="Michael" last="Wilkinson">Michael Wilkinson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Ophthalmology, The Penn State Hershey Medical Center, PA, Hershey</wicri:regionArea>
<wicri:noRegion>Hershey</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Clarke, Loren E" sort="Clarke, Loren E" uniqKey="Clarke L" first="Loren E." last="Clarke">Loren E. Clarke</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, The Penn State Hershey Medical Center, PA, Hershey</wicri:regionArea>
<wicri:noRegion>Hershey</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Cutaneous Pathology</title>
<title level="j" type="alt">JOURNAL OF CUTANEOUS PATHOLOGY</title>
<idno type="ISSN">0303-6987</idno>
<idno type="eISSN">1600-0560</idno>
<imprint>
<biblScope unit="vol">40</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1059">1059</biblScope>
<biblScope unit="page" to="1062">1062</biblScope>
<biblScope unit="page-count">4</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2013-12">2013-12</date>
</imprint>
<idno type="ISSN">0303-6987</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0303-6987</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Angiofibroma (pathology)</term>
<term>Diagnosis, Differential</term>
<term>Eye Neoplasms (pathology)</term>
<term>Female</term>
<term>Giant Cells (pathology)</term>
<term>Humans</term>
<term>Lymphedema (pathology)</term>
<term>Middle Aged</term>
<term>Skin Neoplasms (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Angiofibrome (anatomopathologie)</term>
<term>Cellules géantes (anatomopathologie)</term>
<term>Diagnostic différentiel</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
<term>Tumeurs de l'oeil (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Angiofibrome</term>
<term>Cellules géantes</term>
<term>Lymphoedème</term>
<term>Tumeurs cutanées</term>
<term>Tumeurs de l'oeil</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Angiofibroma</term>
<term>Eye Neoplasms</term>
<term>Giant Cells</term>
<term>Lymphedema</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Diagnostic différentiel</term>
<term>Femelle</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Giant cell angiofibroma represents a rare soft tissue neoplasm with a predilection for the orbit. We recently encountered a mass removed from the lower eyelid of a 56‐year‐old female that histopathologically resembled giant cell angiofibroma. The process consisted of haphazardly arranged CD34‐positive spindled and multinucleated cells within an edematous, densely vascular stroma. However, the patient had recently undergone laryngectomy and radiotherapy for a laryngeal squamous cell carcinoma. A similar mass had arisen on the contralateral eyelid, and both had developed several months post‐therapy. Lymphedema of the orbit can present as tumor‐like nodules and in some cases may share histopathologic features purported to be characteristic of giant cell angiofibroma. A relationship between giant cell angiofibroma and lymphedema has not been established, but our case suggests there may be one. The potential overlap of these two conditions should be recognized, as should other entities that may enter the differential diagnosis.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Lynch, Michael C" sort="Lynch, Michael C" uniqKey="Lynch M" first="Michael C." last="Lynch">Michael C. Lynch</name>
</noRegion>
<name sortKey="Chung, Catherine G" sort="Chung, Catherine G" uniqKey="Chung C" first="Catherine G." last="Chung">Catherine G. Chung</name>
<name sortKey="Clarke, Loren E" sort="Clarke, Loren E" uniqKey="Clarke L" first="Loren E." last="Clarke">Loren E. Clarke</name>
<name sortKey="Lynch, Michael C" sort="Lynch, Michael C" uniqKey="Lynch M" first="Michael C." last="Lynch">Michael C. Lynch</name>
<name sortKey="Specht, Charles S" sort="Specht, Charles S" uniqKey="Specht C" first="Charles S." last="Specht">Charles S. Specht</name>
<name sortKey="Specht, Charles S" sort="Specht, Charles S" uniqKey="Specht C" first="Charles S." last="Specht">Charles S. Specht</name>
<name sortKey="Wilkinson, Michael" sort="Wilkinson, Michael" uniqKey="Wilkinson M" first="Michael" last="Wilkinson">Michael Wilkinson</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B41 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B41 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D4EA5C723196CCF27BF3340577107CE2599821FF
   |texte=   Giant cell angiofibroma or localized periorbital lymphedema?
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024